Why the study?
Does point-of-care creatinine testing agree with laboratory measurements for risk assessment of post-contrast acute kidney injury in patients undergoing angiography?
Does point-of-care creatinine testing agree with laboratory measurements for risk assessment of post-contrast acute kidney injury in patients undergoing angiography?
Point-of-care creatinine testing provides almost perfect diagnostic agreement with standard laboratory measurements for stratifying post-contrast AKI risk in acute angiography settings.
Supports POC creatinine for rapid AKI risk stratification in acute angiography; extends validation to urgent interventional settings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gaipov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: